Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Eletriptan Stories

2013-05-14 08:32:07

Aegis' Intravail® formulation of sumatriptan achieves therapeutic drug levels in approximately 2 to 3 minutes SAN DIEGO, May 14, 2013 /PRNewswire-iReach/ -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,440,631, its second patent providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches which include sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan and...

No Evidence That Adult Drugs Work For Migraines In Children And Teenagers
2013-01-29 08:34:14

Lawrence LeBlond for redOrbit.com - Your Universe Online It is well-known that children and teens can suffer from debilitating migraines as much as adults do. And many of these younger sufferers are often prescribed the same drugs and doses that adults receive for their pulse-pounding headaches. But two recent reviews of pediatric migraine research are digging up some troubling news. According to these reviews, there´s no evidence that most drugs currently prescribed to treat...

34abb942827930bda2c573a236004232
2004-12-01 03:00:00

The words "migraine headache" and "children" do not seem to fit together, however children can experience migraine headaches. In fact, the disorder is much more common in children than previously thought. While complaints of headache are common in almost 70% of children, studies have shown 5% to 15% of children between the ages of 7 and 14 suffer from migraine headaches and 28% of the adolescent population exhibit chronic headache symptoms.'"4 These are large numbers, compared to how...